Patents Assigned to The University of Washington
-
Patent number: 12285636Abstract: Non-planar holographic beam shaping lenses for acoustics are disclosed herein. In one embodiment, an ultrasonic therapy system that is configured to apply ultrasound to a target in a body includes: an ultrasonic transducer configured to generate the ultrasound; and a customizable holographic lens configured to focus the ultrasound onto a focal area of a target that is an object or a portion of the object in the body. The customizable holographic lens is designed and produced based on the target. Furthermore, the customizable holographic lens is curved to mate with a front surface of the ultrasonic transducer.Type: GrantFiled: August 4, 2022Date of Patent: April 29, 2025Assignee: The University of WashingtonInventors: Michael R. Bailey, Mohamed Abdalla Ghanem, Adam D. Maxwell
-
Patent number: 12239376Abstract: Handheld optical imaging devices and methods are disclosed herein. In an embodiment, an optical coherence tomography (OCT) system includes an OCT probe that is configured as a hand-held probe for imaging an eye of a patient, the OCT probe includes: an OCT optical system configured to direct a source OCT signal to the eye and configured to capture OCT scan signal returning from the eye; and an on-probe display carried by a handle, wherein the on-probe display is configured to display imaging data of the eye of a patient to an operator during OCT imaging.Type: GrantFiled: March 27, 2020Date of Patent: March 4, 2025Assignee: The University of WashingtonInventors: Ruikang K. Wang, Shaozhen Song
-
Patent number: 12241901Abstract: Systems and methods for accurate optical pH sensing of biofilms are disclosed. In one embodiment, a method of measuring an extracellular pH level using multiple wavelengths emitted by a fluorescent substance includes: exciting the fluorescent substance at an excitation wavelength; measuring a first fluorescence intensity at a first wavelength of a fluorescence emission; and measuring a second fluorescence intensity at a second wavelength of the fluorescence emission. The second wavelength is different from the first wavelength. The method also includes determining the extracellular pH level based on the first fluorescence intensity at the first wavelength and the second fluorescence intensity at the second wavelength.Type: GrantFiled: July 19, 2019Date of Patent: March 4, 2025Assignee: The University of WashingtonInventors: Eric J. Seibel, Leonard Y. Nelson, Manuja Sharma, Jasmine Graham
-
Patent number: 10829756Abstract: 2-ketoacid decarboxylase enzymes, compositions encoding for 2 ketoacid decarboxylase enzymes, and host cells comprising such enzymes or compositions are provided.Type: GrantFiled: August 29, 2016Date of Patent: November 10, 2020Assignees: The Regents of the University of California, The University of WashingtonInventors: Justin Siegel, Steve Bertolani, Wai Shun Mak, James Liao, Stephen Tran, Ryan Marcheschi, James Thompson, David Baker
-
Patent number: 10301446Abstract: A method for generating a microstructure that includes microcellular bubbles, in a material that includes molecules of a thermoplastic polymer, comprises: determining a size-index for the material that represents an average size of the thermoplastic polymer molecules included in the material, and in response to the determined size-index, setting a parameter of a process to generate a microstructure in the material that includes microcellular bubbles. The process to generate a microstructure in the material includes: 1) infusing into the material, during a first period, a gas that does not react with the material, 2) making the gas-infused material thermodynamically unstable.Type: GrantFiled: September 19, 2014Date of Patent: May 28, 2019Assignees: Dart Container Corporation, The University of Washington through its Center for CommercializationInventors: Krishna V. Nadella, Vipin Kumar, Huimin Guo
-
Patent number: 10202588Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.Type: GrantFiled: April 27, 2012Date of Patent: February 12, 2019Assignee: The University of WashingtonInventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
-
Patent number: 10029401Abstract: The invention disclosed herein relates to relates to foamed thermoplastic material objects and articles of manufacture having an internal layered cellular structure, as well as to methods of making the same. In one embodiment, the invention is directed to a multi-layer foamed polymeric article of manufacture, comprising: a non-laminated multi-layer thermoplastic material sheet, wherein the multi-layer thermoplastic material sheet has first and second discrete outer layers sandwiching a plurality of discrete inner foamed layers, and wherein the two outer layers and plurality discrete inner foamed layers are integral with one another. The thermoplastic material may be a semi-crystalline polymer such as, for example, PET (polyethylene terephthalate), PEEK (polyetheretherketone), PEN (polyethylene naphthalate), PBT (polybutylene terephthalate), PMMA (polymethyl methacrylate), PLA (polylactide), polyhydroxy acid (PHA), thermoplastic urethane (TPU), or blends thereof.Type: GrantFiled: September 14, 2012Date of Patent: July 24, 2018Assignees: Dart Container Corporation, The University of WashingtonInventors: Krishna Nadella, Gregory Branch, Vipin Kumar, Michael Waggoner
-
Patent number: 9477307Abstract: Methods, articles of manufacture, and devices related to generating six degree of freedom (DOF) haptic feedback are provided. A computing device can receive first depth data about an environment. The computing device can generate a first plurality of points from the first depth data. The computing device can determine a virtual tool, where the virtual tool is specified in terms of a translation component for the virtual tool and a rotation component for the virtual tool. The computing device can determine a first force vector between the virtual tool and the first plurality of points. The computing device can send a first indication of haptic feedback based on the first force vector.Type: GrantFiled: January 24, 2014Date of Patent: October 25, 2016Assignee: The University of WashingtonInventors: Howard Jay Chizeck, Fredrik Ryden
-
Patent number: 9471142Abstract: Methods, articles of manufacture, and devices related to generating haptic feedback for point clouds are provided. A computing device receives depth data about an In-Contact environment. The computing device generates a point cloud from the depth data. The computing device determines a haptic interface point (HIP). The computing device determines a haptic interface point (HIP). The computing device determines a force vector between the HIP and point cloud. The computing device sends an indication of haptic feedback based on the force vector.Type: GrantFiled: June 15, 2012Date of Patent: October 18, 2016Assignee: The University of WashingtonInventors: Howard Jay Chizeck, Fredrik Rydén, Sina Nia Kosari, Blake Hannaford, Nicklas Gustafsson, Hawkeye I. King
-
Patent number: 9260529Abstract: The present invention provides novel CD180 binding molecules, methods for their identification, and methods for their use.Type: GrantFiled: February 24, 2011Date of Patent: February 16, 2016Assignee: The University of Washington Through Its Center For CommercializationInventors: Martha Hayden-Ledbetter, Jeffrey Ledbetter
-
Publication number: 20150030631Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.Type: ApplicationFiled: October 3, 2014Publication date: January 29, 2015Applicants: VICAL INCORPORATED, The University of WashingtonInventors: ADRIAN VILALTA, MICHAL MARGALITH, LICHUN DONG, DAVID M. KOELLE
-
Publication number: 20150010597Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2, VP11/12, and VP13/14 polypeptides.Type: ApplicationFiled: September 17, 2014Publication date: January 8, 2015Applicants: Vical Incorporated, The University Of WashingtonInventors: Adrian VILALTA, Michal Margalith, Lichun Dong, David M. Koelle
-
Publication number: 20150010596Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.Type: ApplicationFiled: September 12, 2014Publication date: January 8, 2015Applicants: Vical Incorporated, The University of WashingtonInventors: Adrian VILALTA, Michal Margalith, Lichun Dong, David M. Koelle
-
Patent number: 8852610Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.Type: GrantFiled: August 14, 2012Date of Patent: October 7, 2014Assignees: Vical Incorporated, The University of WashingtonInventors: Adrian Vilalta, Michal Maragalith, Lichun Dong, David M. Koelle
-
Patent number: 8852611Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.Type: GrantFiled: August 14, 2012Date of Patent: October 7, 2014Assignees: Vical Incorporated, The University of WashingtonInventors: Adrian Vilalta, Michal Maragalith, Lichun Dong, David M. Koelle
-
Patent number: 8846387Abstract: This invention provides methods for obtaining targeted gene modification in vertebrate cells using parvoviral vectors, including adeno-associated virus (AAV). The parvoviral vectors used in the methods of the invention are capable of targeting a specific genetic modification to a preselected target locus in a cellular genome by homologous pairing.Type: GrantFiled: May 24, 2011Date of Patent: September 30, 2014Assignee: The University of WashingtonInventors: David W. Russell, Roli K. Hirata
-
Patent number: 8840904Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV VP11/12 polypeptides.Type: GrantFiled: March 15, 2013Date of Patent: September 23, 2014Assignees: Vical Incorporated, The University of WashingtonInventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
-
Patent number: 8834894Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2 polypeptides.Type: GrantFiled: March 15, 2013Date of Patent: September 16, 2014Assignees: Vical Incorporated, The University of WashingtonInventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
-
Patent number: 8828408Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV VP13/14 polypeptides.Type: GrantFiled: March 15, 2013Date of Patent: September 9, 2014Assignees: Vical Incorporated, The University of WashingtonInventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
-
Patent number: 8673216Abstract: The invention provides devices, systems, and methods for detecting an analyte vapor. Particularly, electronegative analyte vapors, such as those vapors evolving from explosive compounds, are typical analytes detected the devices. The devices operate using a resistivity change mechanism wherein a nanostructured chemiresistive material undergoes a resistivity change in the presence of an analyte vapor. A resistivity change indicates the presence of an analyte.Type: GrantFiled: December 3, 2010Date of Patent: March 18, 2014Assignee: The University of WashingtonInventors: Antao Chen, Danling Wang, Qifeng Zhang, Guozhong Cao